LoginSign Up
← Back to all sparks
M

monitOS

ANALYTICS
Velocity0.0

Monitoring overall survival in pivotal trials for indolent cancer

github.com/Novartis/monitOS ↗

monitOS relicenses to MIT, the clearest signal in a sparse Novartis release feed.

clinical trialsoverall survivalnovartisshinyopen source licensing
◆Current state
monitOS is Novartis's R package for monitoring overall survival in clinical trials, with an accompanying Shiny app. The 0.1.6 release changes the licence to MIT, fixes a shiny import problem and an infinite-value bug in the app, and adds spell checking plus issue-tracker and website links. The prior release carries no notes at all beyond a link to the commit history.
◆Where it's heading
For a package published by a pharmaceutical sponsor, the licence change is the substantive item — MIT removes friction for reuse outside Novartis, and the added issue link and website point the same way, toward outside users. Everything else is packaging hygiene. At 0.1.6 with two releases nine months apart, the statistical methodology looks settled while the distribution around it is being tidied.
◆Prediction
The open-sourcing signals suggest the next release will respond to outside issue reports; the entries give no indication of methodology changes.

◆Recent moves

  1. 1y ago

    Relicensed to MIT; Shiny import and inf-value fixes

    The licence moves to MIT and the Shiny app stops returning infinite values, alongside new issue-tracker and website links. Packaging changes aimed at users outside Novartis rather than changes to the monitoring methodology.

    View source ↗
  2. 1y ago

    v0.1.5-release

    A release carrying no notes beyond a link to the commit history. Nothing here indicates what changed for users.

    View source ↗